Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01866657 · ClinicalTrials.gov registry record · NA
Cerebral Oximetry in Single Lung Ventilation Thoracic Surgery
A NA study, sponsored by University Hospitals Cleveland Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 74
- Enrollment target
NCT01866657: Clinical Trial NA study, sponsored by University Hospitals Cleveland Medical Center.
NCT01866657 is a NA study that was terminated before completion, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 74 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01866657, a NA study, was terminated before completion, sponsored by University Hospitals Cleveland Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
Study Summary
This is a prospective, randomized controlled pilot study of cerebral oximetry use in elderly patients undergoing thoracic surgical procedures that require the use of single lung ventilation. The hypothesis is that subjects randomized to open cerebral oximetry monitoring that have active intervention to mitigate observed desaturations will have measurable postoperative clinical outcome benefits when compared to the patients randomized to blinded cerebral oximetry monitoring with no active interventions to mitigate desaturations.
Primary Outcome
The clinical endpoints are defined by the clinical outcome variables assessed and include relationship of assignment group and AUC of cerebral desats and their observed relationship to PACU/hospital/ICU LOS, AUC of mean arterial blood pressure, IV vasoactive drugs, intraop mLs urine/kg/hr in OR, red blood cell(RBC) transfusion, change in surgical procedure, intra/postop stroke/TIA/MI/afib/AUC glucose \> 110 mg/dL, OR time, narcotic administered in the OR, volume of crystalloid/colloid administer
Interventions
- DRUG Vasoconstrictor Agents
- OTHER Head/neck repositioning
- OTHER Increase ETCO2
- OTHER IV fluid bolus
- DRUG Additional anesthesia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2013-06 |
| Est. Completion | 2016-11-10 |
| Phase | NA |
Why NCT01866657 stopped before completion
NCT01866657 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 5 interventions - of which Vasoconstrictor Agents is the first listed.
NCT01866657 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01866657 about?
NCT01866657 is a clinical study titled "Cerebral Oximetry in Single Lung Ventilation Thoracic Surgery". This is a prospective, randomized controlled pilot study of cerebral oximetry use in elderly patients undergoing thoracic surgical procedures that require the use of single lung ventilation. The hypothesis is that subjects randomized to open cerebral oximetry monitoring that have active intervention...
What is the current status of trial NCT01866657?
This trial is currently terminated. It is a NA study. The enrollment target is 74 participants. The study started on 2013-06. Estimated completion is 2016-11-10.
What interventions are being tested in trial NCT01866657?
The interventions under investigation include: Vasoconstrictor Agents (DRUG), Head/neck repositioning (OTHER), Increase ETCO2 (OTHER), IV fluid bolus (OTHER), Additional anesthesia (DRUG).
Who is sponsoring clinical trial NCT01866657?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01866657's enrollment target sits among peer trials
74 1082nd of 2000 higher than 912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia